These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

369 related items for PubMed ID: 22185819

  • 1. Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genes.
    Tin AS, Sundar SN, Tran KQ, Park AH, Poindexter KM, Firestone GL.
    Anticancer Drugs; 2012 Apr; 23(4):370-9. PubMed ID: 22185819
    [Abstract] [Full Text] [Related]

  • 2. Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.
    Tran KQ, Tin AS, Firestone GL.
    Anticancer Drugs; 2014 Mar; 25(3):270-81. PubMed ID: 24296733
    [Abstract] [Full Text] [Related]

  • 3. Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression.
    Willoughby JA, Sundar SN, Cheung M, Tin AS, Modiano J, Firestone GL.
    J Biol Chem; 2009 Jan 23; 284(4):2203-13. PubMed ID: 19017637
    [Abstract] [Full Text] [Related]

  • 4. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
    Tanaka S, Suzuki K, Sakaguchi M.
    Breast Cancer; 2017 Sep 23; 24(5):658-666. PubMed ID: 28070831
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin induces G1 arrest by up-regulating GSK3β and down-regulating CDK4/cyclin D1 and CDK2/cyclin E1 in human primary colorectal cancer cells.
    Chen MJ, Cheng AC, Lee MF, Hsu YC.
    J Cell Physiol; 2018 Jun 23; 233(6):4618-4625. PubMed ID: 28833099
    [Abstract] [Full Text] [Related]

  • 6. Anti-HER2 antibody trastuzumab inhibits CDK2-mediated NPAT and histone H4 expression via the PI3K pathway.
    Le XF, Bedrosian I, Mao W, Murray M, Lu Z, Keyomarsi K, Lee MH, Zhao J, Bast RC.
    Cell Cycle; 2006 Aug 23; 5(15):1654-61. PubMed ID: 16861913
    [Abstract] [Full Text] [Related]

  • 7. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
    Chen XZ, Cao ZY, Chen TS, Zhang YQ, Liu ZZ, Su YT, Liao LM, Du J.
    Oncol Rep; 2012 Aug 23; 28(2):742-8. PubMed ID: 22641337
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. BZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.
    Marconett CN, Morgenstern TJ, San Roman AK, Sundar SN, Singhal AK, Firestone GL.
    Cancer Biol Ther; 2010 Aug 15; 10(4):397-405. PubMed ID: 20574166
    [Abstract] [Full Text] [Related]

  • 11. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M, Zeng C, Lu X, He X, Zhang R, Qiu Q, Zheng G, Jia X, Liu H, He Z.
    Cancer Lett; 2017 Sep 10; 403():175-185. PubMed ID: 28634044
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
    Ni HJ, Chang YN, Kao PH, Chai SP, Hsieh YH, Wang DH, Fong JC.
    Biochim Biophys Acta; 2012 Dec 10; 1820(12):1893-900. PubMed ID: 22906975
    [Abstract] [Full Text] [Related]

  • 16. Aspongopus chinensis ach-miR-276a-3p induces breast cancer cell cycle arrest by targeting APPL2 to regulate the CDK2-Rb-E2F1 signaling pathway.
    Cai R, Khan S, Chen X, Li H, Tan J, Tian Y, Zhao S, Yin Z, Liu T, Jin D, Guo J.
    Toxicol Appl Pharmacol; 2024 Mar 10; 484():116877. PubMed ID: 38431228
    [Abstract] [Full Text] [Related]

  • 17. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
    Sun F, Li N, Tong X, Zeng J, He S, Gai T, Bai Y, Liu L, Lu K, Shen J, Han M, Lu C, Dai F.
    Cell Cycle; 2019 Sep 10; 18(18):2293-2306. PubMed ID: 31322047
    [Abstract] [Full Text] [Related]

  • 18. Anti-tumor potential of 15,16-dihydrotanshinone I against breast adenocarcinoma through inducing G1 arrest and apoptosis.
    Tsai SL, Suk FM, Wang CI, Liu DZ, Hou WC, Lin PJ, Hung LF, Liang YC.
    Biochem Pharmacol; 2007 Dec 03; 74(11):1575-86. PubMed ID: 17869226
    [Abstract] [Full Text] [Related]

  • 19. CSF-1 activates MAPK-dependent and p53-independent pathways to induce growth arrest of hormone-dependent human breast cancer cells.
    Lee AW, Nambirajan S, Moffat JG.
    Oncogene; 1999 Dec 09; 18(52):7477-94. PubMed ID: 10602507
    [Abstract] [Full Text] [Related]

  • 20. Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells.
    Gao X, Han L, Ding N, Mu Y, Guan P, Hu C, Huang X.
    J Antibiot (Tokyo); 2018 Sep 09; 71(9):808-817. PubMed ID: 29752478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.